论文部分内容阅读
目的:探讨分析应用复方丹参片联合奥美拉唑肠溶片治疗门脉高压性胃病的临床疗效观察。方法:选取2012年10月~2013年10月间我院收治的门脉高压性胃病患者100例作为研究对象,将其随机分为对照组(50例)和观察组(50例),单纯使用雷尼替丁为对照组患者进行治疗,使用复方丹参片联合奥美拉唑肠溶片为观察组患者进行治疗,观察对比两组患者的临床疗效,并将对比的结果及两组患者的临床资料进行回顾性的分析。结果:在50例对照组患者中,临床疗效判定等级为显效的患者有27例(占患者总数的54%),临床疗效判定等级为有效的患者有12例(占患者总数的24%),临床疗效判定等级为无效的患者有11例(占患者总数的22%),治疗的总有效率为78%。在50例观察组患者中,临床疗效判定等级为显效的患者有42例(占患者总数的84%),临床疗效判定等级为有效的患者有7例(占患者总数的14%),临床疗效判定等级为无效的患者有1例(占患者总数的2%),治疗的总有效率为98%。观察组患者的临床疗效明显优于对照组患者,差异显著(P<0.05),具有统计学意义。结论:应用复方丹参片联合奥美拉唑肠溶片治疗门脉高压性胃病的临床疗效显著,值得在临床上进一步推广应用。
Objective: To investigate the clinical efficacy of Fufang Danshen Tablets combined with omeprazole enteric-coated tablets in the treatment of portal hypertensive gastropathy. Methods: 100 cases of portal hypertensive gastropathy admitted to our hospital from October 2012 to October 2013 were selected as the research object, which were randomly divided into control group (50 cases) and observation group (50 cases) Ranitidine for the control group of patients for treatment, the use of compound Danshen Tablets omeprazole enteric-coated tablets for the observation group of patients treated and compared the clinical efficacy of the two groups were observed and compared the results and the two groups of patients with clinical Data for retrospective analysis. RESULTS: Out of 50 patients in the control group, 27 patients (54% of the total) had a clinically effective decision grade, 12 patients (24% of the patients) had a clinically effective grade of efficacy, Eleven patients (22% of patients) were found to be clinically ineffective and their total effective rate was 78%. Among the 50 patients in the observation group, 42 patients (84% of the total) had a clinically effective judgment grade, 7 patients (14% of the total) had a clinically effective judgment grade, and the clinical efficacy 1 patient (2% of the total number of patients) judged to be ineffective, and the total effective rate of treatment was 98%. The clinical efficacy of the observation group was significantly better than that of the control group, the difference was significant (P <0.05), with statistical significance. Conclusion: The clinical efficacy of Fufang Danshen Tablets combined with omeprazole enteric-coated tablets in the treatment of portal hypertensive gastropathy is significant and worthy of further application in clinic.